Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk.
Keun Ho ParkYoungkeun AhnHyun Kuk KimYoung-Jae KiSung Soo KimDong-Hyun ChoiYoung-Youp KohYoungkeun AhnHyo-Soo KimHyeon Cheol GwonSeung Woon RhaJin Yong Hwangnull nullPublished in: Journal of Korean medical science (2021)
The bleeding risk of ticagrelor was attenuated in Korean patients with AMI without HBR. Appropriate patient selection could reduce in-hospital bleeding complications associated with ticagrelor in Korean patients with AMI who underwent successful PCI.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- atrial fibrillation
- acute coronary syndrome
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- antiplatelet therapy
- coronary artery disease
- coronary artery bypass grafting
- coronary artery bypass
- case report
- healthcare
- left ventricular
- risk factors
- adverse drug
- acute care